SALT LAKE CITY, UT (AUGUST 14, 2017) CibusDx announced today that it has been awarded a US Government STEP Grant and selected to participate in a Trade Mission to Singapore and Vietnam sponsored by Utah Governor Gary Herbert, and the Utah World Trade Center. The Mission is designed to foster new trade relations between Utah, Singapore, and Vietnam. It will be led by Governor Gary Herbert, and will include meetings with potential customers, agents, and government officials. CibusDx and the other members of the delegation will also receive market specific briefings for each location.
“Southeast Asia has both the fastest growing economy and population in the world”, said CibusDx CEO Jared Bauer. “We are honored to attend this trade mission with Governor Herbert and the Utah World Trade Center. Southeast Asia is of particular interest to CibusDx as we are currently developing tests on our system which are critical to the shrimp production industry. Since 75% of all shrimp consumed come from ASEAN nations and China, this mission will permit us to meet with customers, potential industry partners, and government leaders.”
The mission will take place from August 28 to September 1, 2017.
CibusDx is a new Salt Lake City based diagnostic company dedicated to developing a state-of-the-art food safety platform. CibusDx technology offers a new testing paradigm, utilizing advanced technology and decentralized testing in conjunction with backend connectivity to centralized data repositories. For more information about CibusDx please visit our website https://cibusbiotechnologies.com.
NOTICE: This document contains certain forward-looking statements, including without limitation statements regarding CibusDx’s plans for future research and development activities. You are cautioned that such forward-looking statements are not guarantees of future performance and involve risks and uncertainties inherent to CibusDx’s business which could significantly affect expected results, including without limitation progress of product development, ability to raise capital to fund product development, testing and regulatory approval, developments in raw material and personnel costs, and legislative, fiscal, and other regulatory measures. All forward-looking statements are qualified in their entirety by this cautionary statement, and CibusDx undertakes no obligation to revise or update any forward-looking statement to reflect events or circumstances after the issuance of this press release.
Contact: Jared Bauer 801-796-2918 ext. 104